Circulate

Circulate Health is a longevity-focused biotechnology company dedicated to advancing human healthspan through therapeutic plasma exchange (TPE). Co-founded by CEO Dr. Brad Younggren and renowned geroscientist Dr. Eric Verdin of the Buck Institute, the company utilizes a patented procedure to systematically remove inflammatory cytokines and age-related toxins from the bloodstream. Their approach is supported by clinical research published in Aging Cell, which demonstrated a significant reduction in biological age following a series of treatments. Beyond aging, Circulate Health is expanding its platform to address environmental health concerns, including the removal of microplastics and PFAS from human blood. The company operates a growing network of partner clinics across the United States, providing a turnkey solution for clinicians to offer advanced longevity care.